David M. Spencer, Chief Scientific Officer at BELLICUM PHARMACEUTICALS, INC (BLCM), sold 6,200 shares at $20.19 ($125K) on 2016-09-23, disclosed to the SEC on 2016-09-23.
Open-market sale of $125k BLCM by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| BLCM | SELL | 2017-07-12 | $231K | — | Filing → |
| BLCM | SELL | 2016-12-05 | $139K | — | Filing → |
| BLCM | SELL | 2016-12-05 | $100K | — | Filing → |